Mufg Americas Holdings Corp Clovis Oncology, Inc. Transaction History

Mufg Americas Holdings Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 07, 2018	SELL	$50.12 - $67.72 $6,064 - $8,194	-121 Reduced 23.18%	401 $21,000
Q4 2017 Feb 08, 2018	BUY	$57.69 - $84.58 $576 - $845	10 Added 1.95%	522 $0
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $738 - $932	11 Added 2.2%	512 $0
Q2 2017 Aug 07, 2017	BUY	N/A	501	501 $0

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.